Maxair and Naprosyn drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Maxair (pirbuterol acetate) and Naprosyn (naproxen). Common drug interactions include nocturia among females and acute myocardial infarction among males.
The phase IV clinical study analyzes what interactions people have when they take Maxair and Naprosyn. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Maxair?
Maxair has active ingredients of pirbuterol acetate. It is often used in asthma. eHealthMe is studying from 2,903 Maxair users. Check the latest studies of Maxair.
What is Naprosyn?
Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.
15 people who take Maxair and Naprosyn together, and have interactions are studied.

What are the common drug interactions of Maxair and Naprosyn, by gender? *:
female:
- Nocturia (the need to get up in the night to urinate)
- Urge incontinence (urinary incontinence)
- Abdominal distension
- Abdominal pain upper
- Anaemia (lack of blood)
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Anxiety
- Arthropathy
- Asthenia (weakness)
- Balance disorder
male:
- Acute myocardial infarction (acute heart attack)
- Blood cholesterol increased
- Bone cyst
- Bone disorder
- Dyspnoea (difficult or laboured respiration)
- Oedema peripheral (superficial swelling)
- Thrombocytopenia (decrease of platelets in blood)
- Toothache (tooth pain)
What are the common drug interactions of Maxair and Naprosyn, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
20-29:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Pulmonary embolism (blockage of the main artery of the lung)
30-39:
- Acute myocardial infarction (acute heart attack)
- Blood cholesterol increased
- Bone cyst
- Bone disorder
- Dyspnoea (difficult or laboured respiration)
- Oedema peripheral (superficial swelling)
- Toothache (tooth pain)
40-49:
- Sedation
50-59:
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Bladder cancer
- Blood alkaline phosphatase nos increased
- Cough
- Culture urine positive
- Escherichia infection (bacterial infection by escherichia coli)
- Gamma-glutamyltransferase increased
- Haematuria (presence of blood in urine)
- Nocturia (the need to get up in the night to urinate)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
60+:
- Dyspnoea (difficult or laboured respiration)
- Abdominal pain upper
- Stress
- Thrombocytopenia (decrease of platelets in blood)
- Toothache (tooth pain)
- Bone cyst
- Bone disorder
- Diarrhoea
- Fatigue (feeling of tiredness)
- Gastric ulcer (stomach ulcer)
What are the existing conditions these people have? *
- Osteoporosis (bones weak and more likely to break): 2 people, 13.33%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
- Quit Smoking: 1 person, 6.67%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.67%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
- High Blood Pressure: 1 person, 6.67%
- Back Pain: 1 person, 6.67%
- Abdominal Symptom: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Maxair and Naprosyn?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Maxair and Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Maxair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Maxair and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Naprosyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pirbuterol acetate and naproxen (the active ingredients of Maxair and Naprosyn, respectively), and Maxair and Naprosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Meprobamate cause Hypotension? - 12 seconds ago
- Drug interactions of Eliquis and Ciprofloxacin Hydrochloride - 15 seconds ago
- Could Vincristine Sulfate cause Transaminases Increased? - 18 seconds ago
- Could Meprobamate cause Hypothermia? - 22 seconds ago
- Could Meprobamate cause Hypotension Aggravated? - 24 seconds ago
- Could Farydak cause Weight Decreased? - 30 seconds ago
- Could Profen cause Aneurysm? - 35 seconds ago
- Metadate Er vs. Lexapro, side effect and effectiveness comparison - 36 seconds ago
- Could Efavirenz cause Gastroesophageal Reflux Disease? - 40 seconds ago
- Could Plendil cause Gastritis? - 42 seconds ago